Research Shows Promise For Potential New Gene Therapy Strategy For Muscle Wasting Diseases
Investigators in The Research Institute at Nationwide Childrens Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).Results of these studies appear in the March 11, 2008 issue of the Proceedings of the National Academy of Sciences.These studies, led by Brian Kaspar, PhD, a principal investigator in the Center for Gene Therapy at The Research Institute and an assistant professor of Pediatrics at The Ohio State University, focus on a protein called follistatin (FS)....